Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis

Objective: to evaluate the risk of treatment-related adverse events of different severity and different system with PD-1 or PD-L1 inhibitors. Methods: randomized controlled trials (RCTs) that using PD-1/PD-L1 for cancer treatment were searched in the PubMed, Embase, Cochrane Library, and Web of Scie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yixi, La, Bin, Liang, Baosheng, Gu, Yangchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618590/
https://www.ncbi.nlm.nih.gov/pubmed/34833153
http://dx.doi.org/10.3390/life11111277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618590/
https://www.ncbi.nlm.nih.gov/pubmed/34833153
http://dx.doi.org/10.3390/life11111277

Ejemplares similares